Malignant pleural effusions

Surgical Clinics of North America

Volumn 82, Issue 4, 2002, Pages 867-883

  Putnam Jr , Joe B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; THORACOCENTESIS; THORACOSCOPY;

CATHETERIZATION; EQUIPMENT DESIGN; HUMANS; PLEURAL EFFUSION, MALIGNANT;

EID: 0036703919     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(02)00036-1     Document Type: Review

References (43)

1. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162:1987-2001.
2. Antunes G, Neville E. Management of malignant pleural effusions. Thorax 2000;55:981-3.
3. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
4. Light RW. Useful tests on the pleural fluid in the management of patients with pleural effusions. Curr Opin Pulm Med 1999;5:245-9.
5. Light RW. Management of pleural effusions. J Formos Med Assoc 2000;99:523-31.
6. Cheng D, Rodriguez RM, Perkett EA, et al. Vascular endothelial growth factor in pleural fluid. Chest 1999;116:760-5.
7. Zebrowski BK, Yano S, Liu W, et al. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 1999;5:3364-8.
8. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-9.
9. Sanchez-Armengol A, Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993;104:1482-5.
10. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: An assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000;117:73-8.
11. Gazquez I, Porcel JM, Vives M, et al. Comparative analysis of Light's criteria and other biochemical parameters for distinguishing transudates from exudates. Respir Med 1998;92:762-5.
12. Ashchi M, Golish J, Eng P, et al. Transudative malignant pleural effusions: Prevalence and mechanisms. South Med J 1998;91:23-6.
13. Marom EM, Patz EF Jr, Erasmus JJ, et al. Malignant pleural effusions: Treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999;210:277-81.
14. Patz EF Jr. Malignant pleural effusions: Recent advances and ambulatory sclerotherapy. Chest 1998;113:74S-7S.
15. Patz EF Jr, McAdams HP, Erasmus JJ, et al. Sclerotherapy for malignant pleural effusions: A prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998;113:1305-11.
16. Lee KA, Harvey JC, Reich H, et al. Management of malignant pleural effusions with pleuroperitoneal shunting. J Am Coll Surg 1994;178:586-8.
17. Ponn RB, Blancaflor J, D'Agostino RS, et al. Pleuroperitoneal shunting for intractable pleural effusions. Ann Thorac Surg 1991;51:605-9.
18. Aelony Y, King RR, Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions: Effective pleurodesis despite low pleural pH. Chest 1998;113:1007-12.
19. Danby CA, Adebonojo SA, Moritz DM. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and IV sedation. Chest 1998;113:739-42.
20. Jacobi CA, Wenger FA, Schmitz-Rixen T, et al. Talc pleurodesis in recurrent pleural effusions. Langenbecks Arch Surg 1998;383:156-9.
21. de Campos JR, Vargas FS, de Campos WE, et al. Thoracoscopy talc poudrage: A 15-year experience. Chest 2001;119:801-6.
22. Petrakis I, Katsamouris A, Drossitis I, et al. Usefulness of thoracoscopic surgery in the diagnosis and management of thoracic diseases. J Cardiovasc Surg (Torino) 2000;41:767-71.
23. Pien GW, Gant MJ, Washam CL, et al. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001;119:1641-6.
24. Belani CP, Pajeau TS, Bennett CL. Treating malignant pleural effusions cost consciously. Chest 1998;113:78S-85S.
25. Schafers SJ, Dresler CM. Update on talc, bleomycin, and the tetracyclines in the treatment of malignant pleural effusions. Pharmacotherapy 1995;15:228-35.
26. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997;112:430-4.
27. Antony VB. Pathogenesis of malignant pleural effusions and talc pleurodesis. Pneumologie 1999;53:493-8.
28. Hartman DL, Gaither JM, Kesler KA, et al. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993;105:743-7.
29. Olak J, Dresler CM. Sclerosis of pleural effusions by talc thoracoscopy versus talc slurry: A Phase III study. Cancer and Leukemia Group B (CALGB #9334). 1993.
30. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994;106:342-6.
31. Martinez Moragon E, Aparicio Urtasun J, Sanchis Aldas J, et al. Pleurodesis con tetraciclinas en el tratamiento del derrame pleural maligno. Estudio retrospectivo de 91 casos [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases]. Med Clin 1993;101:201-4.
32. Herrington JD, Gora-Harper ML, Salley RK. Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy 1996;16:280-5.
33. Prevost A, Nazeyrollas P, Milosevic D, et al. Malignant pleural effusions treated with high dose intrapleural doxycycline: Clinical efficacy and tolerance. Oncol Rep 1998;5:363-6.
34. Noppen M, Degreve J, Mignolet M, et al. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions. Acta Clin Belg 1997;52:258-62.
35. Ong KC, Indumathi V, Raghuram J, et al. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000;5:99-103.
36. Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: Thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001;71:1809-12.
37. Pollak JS, Burdge CM, Rosenblatt M, et al. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 2001;12:201-8.
38. Saffran L, Ost DE, Fein AM, et al. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000;118:417-21.
39. Smart JM, Tung KT. Initial experiences with a long-term indwelling tunnelled pleural catheter for the management of malignant pleural effusion. Clin Radiol 2000;55:882-4.
40. Goff BA, Mueller PR, Muntz HG, et al. Small chest-tube drainage followed by bleomycin sclerosis for malignant pleural effusions. Obstet Gynecol 1993;81:993-6.
41. Hsu WH, Chiang CD, Chen CY, et al. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. Jpn J Clin Oncol 1998;28:187-91.
42. Parulekar W, Di Primio G, Matzinger F, et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 2001;120:19-25.
43. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-75.